Centre René Gauducheau

Saint-Herblain 44805

0 studies enrolling now · 3 studies all time

What they study most

Metastatic Pancreatic Adenocarcinoma, Prostate Cancer, Refractory Metastatic Gastric Cancer

Studies at this site

• Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer — Completed
• A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC — Stopped early
• A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) — Completed